Preventing and managing toxicities of high-dose methotrexate

SC Howard, J McCormick, CH Pui… - The …, 2016 - academic.oup.com
Abstract High-dose methotrexate (HDMTX), defined as a dose higher than 500 mg/m2, is
used to treat a range of adult and childhood cancers. Although HDMTX is safely …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

[HTML][HTML] Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022

J Robijns, RG Nair, J Lodewijckx, P Arany… - Frontiers in …, 2022 - frontiersin.org
Disclaimer This article is based on recommendations from the 12th WALT Congress, Nice,
October 3-6, 2018, and a follow-up review of the existing data and the clinical observations …

[HTML][HTML] A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis

S Yang, S Chu, Y Gao, Q Ai, Y Liu, X Li, N Chen - Cells, 2019 - mdpi.com
Many cancer patients suffer from severe fatigue when treated with chemotherapy or
radiotherapy; however, the etiology and pathogenesis of this kind of fatigue remains …

Oral complications of cancer and cancer therapy: from cancer treatment to survivorship

JB Epstein, J Thariat, RJ Bensadoun… - CA: a cancer journal …, 2012 - Wiley Online Library
Answer questions and earn CME/CNE Oral complications resulting from cancer and cancer
therapies cause acute and late toxicities that may be underreported, underrecognized, and …

Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and …

JAEM Zecha, JE Raber-Durlacher, RG Nair… - Supportive Care in …, 2016 - Springer
Purpose There is a large body of evidence supporting the efficacy of low-level laser therapy
(LLLT), more recently termed photobiomodulation (PBM) for the management of oral …

[HTML][HTML] Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment

A Laborda-Illanes, L Sanchez-Alcoholado… - Cancers, 2020 - mdpi.com
Simple Summary In this review we discuss the recent knowledge about the role of breast
and gut microbiome in the pathogenesis of breast cancer. We examine the proposed …

[HTML][HTML] Oncological-therapy related oral mucositis as an interdisciplinary problem—literature review

A Kusiak, BA Jereczek-Fossa, D Cichońska… - International journal of …, 2020 - mdpi.com
Oral mucositis is a toxic side effect of non-surgical cancer treatments: chemotherapy and
radiotherapy, which strongly impair quality of life and can not only cause strong pain, but …

Emerging evidence on the pathobiology of mucositis

N Al-Dasooqi, ST Sonis, JM Bowen, E Bateman… - Supportive care in …, 2013 - Springer
Background Considerable progress has been made in our understanding of the biological
basis for cancer therapy-induced mucosal barrier injury (mucositis). The last formal review of …

[HTML][HTML] Oral mucositis induced by anticancer therapies

S Al-Ansari, JAEM Zecha, A Barasch, J de Lange… - Current oral health …, 2015 - Springer
Oral mucositis induced by conventional cytotoxic cancer therapies is a common and
significant clinical problem in oncology. Mucositis symptoms, which include severe pain …